Piramal Pharma Ltd
NSE:PPLPHARMA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Piramal Pharma Ltd
NSE:PPLPHARMA
|
IN |
|
V
|
Viohalco SA
ATHEX:VIO
|
BE |
|
Haivision Systems Inc
TSX:HAI
|
CA |
|
MNP Petroleum Corp
OTC:MNAP
|
CH |
|
Lenta Plc
LSE:LNTA
|
RU |
|
J
|
Jayshree Chemicals Ltd
BSE:506520
|
IN |
|
Xbrane Biopharma AB
STO:XBRANE
|
SE |
|
Dawn Corp
TSE:2303
|
JP |
|
Diamcor Mining Inc
XTSX:DMI
|
CA |
|
One Liberty Properties Inc
NYSE:OLP
|
US |
|
FIH Mobile Ltd
HKEX:2038
|
CN |
|
Greenbriar Capital Corp
XTSX:GRB
|
CA |
|
Southern Michigan Bancorp Inc
OTC:SOMC
|
US |
Bankruptcy Probability
Piramal Pharma Ltd's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Piramal Pharma Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IN |
P
|
Piramal Pharma Ltd
NSE:PPLPHARMA
|
193.7B INR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
871.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
578.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
231.4B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
296.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
230.8B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
154.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
GlaxoSmithKline PLC
LSE:GSK
|
89.3B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Piramal Pharma Ltd's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Piramal Pharma Ltd has total debt of 34.2B INR. This includes both short-term (0 INR) and long-term (34.2B INR) debt.
You can find a full breakdown on its Balance Sheet.
